Exhibit 23.2
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in this Registration Statement of Navidea Biopharmaceuticals, Inc. on Form S-3 of our report dated March 31, 2017, except for Note 3, as to which the date is December 15, 2017, which includes explanatory paragraphs as to our audit of adjustments to retroactively apply discontinued operations reporting related to the sale of certain assets to Cardinal Health 414, LLC that occurred subsequent to December 31, 2016, to the 2015 and 2014 financial statements which were audited by other auditors, with respect to our audit of the consolidated financial statements of Navidea Biopharmaceuticals, Inc. as of December 31, 2016 and for the year then ended and our report dated March 31, 2017 with respect to our audit of the effectiveness of internal control over financial reporting of Navidea Biopharmaceuticals, Inc. as of December 31, 2016 appearing in the Annual Report on Form 10-K of Navidea Biopharmaceuticals, Inc. for the year ended December 31, 2016. Our report on the effectiveness of internal control over financial reporting expressed an adverse opinion because of the existence of material weaknesses. We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ Marcum llp
New Haven, CT
December 15, 2017
